SBC Medical Group Holdings Inc (SBC) EBIT (2023 - 2026)
SBC Medical Group Holdings' (SBC) quarterly EBIT came in at $12.8 million in Q4 2025, up 172.36% YoY from $4.7 million in Q4 2024, and down 19.09% on a QoQ basis from $15.9 million in Q3 2025.
SBC Medical Group Holdings Inc (SBC) EBIT (2023 - 2026) Analysis & Trends
SBC Medical Group Holdings (SBC) has 3 years of EBIT data on file, last reported at $12.8 million in Q4 2025.
- Quarterly EBIT rose 172.36% year-over-year to $12.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.5 million (down 4.01% YoY) and the FY2025 annual result came in at $67.5 million, down 4.01% from the prior year.
- EBIT slipped to $12.8 million in Q4 2025, from $15.9 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $27.3 million in Q2 2024 to a low of -$473374.0 in Q2 2023.
- A 3-year average of $15.1 million and a median of $15.2 million in 2025 frame the typical range for EBIT.
- The widest YoY moves for EBIT: up 6397.1% in 2024, down 80.33% in 2024.
- Tracing SBC's EBIT over 3 years: stood at $24.0 million in 2023, then plunged by 80.33% to $4.7 million in 2024, then soared by 172.36% to $12.8 million in 2025.
- The last three EBIT figures came in at $12.8 million (Q4 2025), $15.9 million (Q3 2025), and $14.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.96 Mn |
| Dec 31, 2025 | 12.85 Mn |
| Sep 30, 2025 | 15.88 Mn |
| Jun 30, 2025 | 14.55 Mn |
| Mar 31, 2025 | 24.20 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 13.83 Mn |
| Jun 30, 2024 | 27.29 Mn |
| Mar 31, 2024 | 24.46 Mn |
| Dec 31, 2023 | 23.99 Mn |
| Sep 30, 2023 | 20.02 Mn |
| Jun 30, 2023 | -473,374.00 |
| Mar 31, 2023 | -388,447.00 |